It has a similar tolerability profile to other SSRIs.<ref name="pmid18494538">{{cite journal | author = Papakostas GI | title = Tolerability of modern antidepressants | journal = J Clin Psychiatry | volume = 69 | issue = Suppl E1 | pages = 8–13 | year = 2008 | pmid = 18494538 |registration=yes }}</ref> The common side effects include drowsiness, dry mouth, loss of appetite, sweating, [[insomnia|trouble sleeping]] and [[delayed ejaculation]]. It may also be associated with a slightly increased risk of birth defects.<ref name="Committee2006">{{cite journal |author=ACOG Committee on Obstetric Practice | title = ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy | journal = Obstet Gynecol | volume = 108 | issue = 6 | pages = 1601–3 |date=December 2006 | pmid = 17138801 | doi = 10.1097/00006250-200612000-00058 |subscription=yes }}</ref><ref name=pmid24313569>{{cite journal|last1=Yonkers|first1=KA|last2=Blackwell|first2=KA|last3=Glover|first3=J|last4=Forray|first4=A|title=Antidepressant use in pregnant and postpartum women.|journal=Annual Review of Clinical Psychology|date=2014|volume=10|pages=369–92|pmid=24313569|doi=10.1146/annurev-clinpsy-032813-153626|pmc=4138492}}</ref> The rate of withdrawal symptoms in young people may be higher with paroxetine and [[venlafaxine]] than other SSRIs and SNRIs.<ref>{{Cite journal|title = SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents|journal = Journal of the Canadian Academy of Child and Adolescent Psychiatry|date = February 2011 |issn = 1719-8429|pmc = 3024727|pmid = 21286371|pages = 60–67|volume = 20|issue = 1|first = Sheik|last = Hosenbocus|first2 = Raj|last2 = Chahal}}</ref> Several studies have associated paroxetine with suicidal thinking and behavior in children and adolescents.<ref>{{Cite journal|title = Evaluation of Suicidal Thoughts and Behaviors in Children and Adolescents Taking Paroxetine|url = http://online.liebertpub.com/doi/abs/10.1089/cap.2006.16.77 |url-access=subscription |journal = Journal of Child and Adolescent Psychopharmacology|date = 2006-03-01|issn = 1044-5463|pages = 77–90|volume = 16|issue = 1-2|doi = 10.1089/cap.2006.16.77|first = Alan|last = Apter|first2 = Alan|last2 = Lipschitz|first3 = Regan|last3 = Fong|first4 = David J.|last4 = Carpenter|first5 = Stan|last5 = Krulewicz|first6 = John T.|last6 = Davies|first7 = Christel|last7 = Wilkinson|first8 = Philip|last8 = Perera|first9 = Alan|last9 = Metz|pmid=16553530}}</ref>

 

